Deciphera Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DECIPHERA PHARMS, and what generic alternatives to DECIPHERA PHARMS drugs are available?
DECIPHERA PHARMS has one approved drug.
There are twenty-four US patents protecting DECIPHERA PHARMS drugs.
There are seventy-six patent family members on DECIPHERA PHARMS drugs in twenty countries.
Summary for Deciphera Pharms
International Patents: | 76 |
US Patents: | 24 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for Deciphera Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,896,585 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,344,536 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,576,903 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,612,591 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,433,056 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Deciphera Pharms | QINLOCK | ripretinib | TABLET;ORAL | 213973-001 | May 15, 2020 | RX | Yes | Yes | 11,850,241 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Deciphera Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Mexico | 2022008103 | ⤷ Try a Trial |
South Korea | 20090067175 | ⤷ Try a Trial |
Brazil | 112022013109 | ⤷ Try a Trial |
Canada | 2664009 | ⤷ Try a Trial |
European Patent Office | 4022617 | ⤷ Try a Trial |
Canada | 3150433 | ⤷ Try a Trial |
Finland | 4084778 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.